Evidence map›Paper›PMID 29172939›Full record

ArticlePlant signaling & behavior2017

Rice ERECT LEAF 1 acts in an alternative brassinosteroid signaling pathway independent of the receptor kinase OsBRI1.

Tomoaki Sakamoto, Hidemi Kitano, Shozo Fujioka

Abstract read
In one paragraph

Article in Plant signaling & behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tomoaki Sakamotoa Department of Bioproduction Science , Faculty of Bioresources and Environmental Sciences, Ishikawa Prefectural University , Ishikawa , Japan.
Hidemi Kitanob Bioscience and Biotechnology Center , Nagoya University , Aichi , Japan.
Shozo Fujiokac RIKEN Advanced Science Institute , Saitama , Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ERECT LEAF 1 (ELF1) was previously identified as a component of brassinosteroid signaling in rice. A double mutant obtained by crossing elf1-1 (a null mutant of ELF1) with d61-1 (a leaky mutant of OsBRI1) showed a more severe phenotype than did the elf1-1 single mutant, resembling that of a severe brassinosteroid-deficient mutant. Microarray analysis showed that the gene expression profile of elf1-1 was distinct from that of d61-12 (a leaky mutant of OsBRI1 with a phenotype similar to that of elf1-1), and fewer than half of genes differentially expressed between the wild-type and elf1-1 showed similar differences in d61-12 relative to the wild-type. These results indicate that less than half of ELF1-regulated genes in rice seedlings are affected by OsBRI1, and suggest that ELF1 acts in a rice brassinosteroid signaling pathway different from that initiated by OsBRI1. Gene expression analysis showed that some stress response-related genes were induced in elf1-1 but not in d61-12, and 8 of 9 genes oppositely regulated in elf1-1 and d61-12 were significantly up- or down-regulated in both elf1-1 and jasmonic acid-treated wild-type. These results imply that ELF1 suppresses stress-induced signalling, and that jasmonic acid signaling is stimulated in elf1-1; therefore, ELF1 may be involved in the brassinosteroid-mediated suppression of jasmonic acid response in rice.

Indexed as

Signal TransductionBrassinosteroidsCrosses, GeneticGene Expression ProfilingGene Expression Regulation, PlantGenes, PlantMutationOryzaPhenotypePlant Growth RegulatorsPlant ProteinsPollinationBrassinosteroidsPlant Growth RegulatorsPlant ProteinsBrassinosteroid insensitivebrassinosteroid signalingjasmonic acidmicroarraymutant, rice

Identifiers

PMID29172939
PMCPMC5792126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.